Bacchus Vascular Overview
- Year Founded
-
1999
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
Bacchus Vascular General Information
Description
Developer of medical devices and provides treatments for peripheral vascular disease. The company develops procedure to percutaneously remove blood clots from dialysis and peripheral grafts as well as native arteries and veins.
Contact Information
Website
www.bacchus-vascular.comCorporate Office
- 3110 Coronado Drive
- Santa Clara, CA 95054
- United States
Corporate Office
- 3110 Coronado Drive
- Santa Clara, CA 95054
- United States
Bacchus Vascular Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
8. Merger/Acquisition | 06-Mar-2009 | 000.00 | Completed | Generating Revenue | ||
7. Later Stage VC | 13-Feb-2008 | 0000 | 000.00 | Completed | Generating Revenue | |
6. Later Stage VC (Series A1) | 17-Dec-2007 | 00.00 | 000.00 | 000.00 | Completed | Product Development |
5. Later Stage VC (Series A1) | 19-Oct-2007 | 000.00 | 000.00 | 000.00 | Completed | Product Development |
4. Later Stage VC (Series D) | 09-Jul-2003 | 0000 | 000.00 | 0000 | Completed | Generating Revenue |
3. Later Stage VC (Series C) | 15-Nov-2001 | 00.000 | 000.00 | 000.00 | Completed | Startup |
2. Early Stage VC (Series B) | 03-May-2000 | $7.18M | $8.39M | 0000 | Completed | Startup |
1. Early Stage VC (Series A) | 26-May-1999 | $1.22M | $1.22M | 00.000 | Completed | Startup |
Bacchus Vascular Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series A1 | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Bacchus Vascular Patents
Bacchus Vascular Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
AU-2003286518-A1 | Apparatus and methods for clot dissolution | Inactive | 21-Oct-2002 | 0000000000000 | |
AU-2003286518-A8 | Apparatus and methods for clot dissolution | Inactive | 21-Oct-2002 | 0000000000000 | |
AU-2003234601-A1 | Apparatus and method for removing occlusive material within blood vessels | Inactive | 14-May-2002 | 00000000000 | |
AU-2003234601-A8 | Apparatus and method for removing occlusive material within blood vessels | Inactive | 14-May-2002 | 00000000000 | |
AU-2002308583-A1 | Apparatus and methods for capturing particulate material within blood vessels | Inactive | 21-May-2001 | A61B17/22 |
Bacchus Vascular Former Investors (8)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Atherton Venture Partners | Venture Capital | Minority | 000 0000 | 000000 0 |
De Novo Ventures | Venture Capital | Minority | 000 0000 | 000000 0 |
Frantz Medical Ventures | Corporate Venture Capital | Minority | 000 0000 | 000000 0 |
Kaiser Permanente Ventures | Corporate Venture Capital | Minority | 000 0000 | 000000 0 |
Saratoga Ventures | Venture Capital | Minority | 000 0000 | 000000 0 |
Bacchus Vascular FAQs
-
When was Bacchus Vascular founded?
Bacchus Vascular was founded in 1999.
-
Where is Bacchus Vascular headquartered?
Bacchus Vascular is headquartered in Santa Clara, CA.
-
What industry is Bacchus Vascular in?
Bacchus Vascular’s primary industry is Medical Supplies.
-
Is Bacchus Vascular a private or public company?
Bacchus Vascular is a Private company.
-
What is Bacchus Vascular’s current revenue?
The current revenue for Bacchus Vascular is 000000.
-
How much funding has Bacchus Vascular raised over time?
Bacchus Vascular has raised $80.3M.
-
Who are Bacchus Vascular’s investors?
Atherton Venture Partners, De Novo Ventures, Frantz Medical Ventures, Kaiser Permanente Ventures, and Saratoga Ventures are 5 of 8 investors who have invested in Bacchus Vascular.
-
When was Bacchus Vascular acquired?
Bacchus Vascular was acquired on 06-Mar-2009.
-
Who acquired Bacchus Vascular?
Bacchus Vascular was acquired by Covidien.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »